Cambridge, Massachusetts, United States LSP BioVentures is the famous VC, which was founded in 2006. The company was established in North America in United States. The main department of described VC is located in the Cambridge.
We also calculated 10 valuable employees in our database.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Lumeon, Nouscom, Rainier Therapeutics. We can highlight the next thriving fund investment areas, such as Therapeutics, Medical. The fund has exact preference in a number of founders of portfolio startups. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
Opposing the other organizations, this LSP BioVentures works on 21 percentage points more the average amount of lead investments. The fund is constantly included in less than 2 deals per year. Considering the real fund results, this VC is 44 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2017. Despite it in 2019 the fund had an activity. The increased amount of exits for fund were in 2017. The common things for fund are deals in the range of 10 - 50 millions dollars.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the LSP BioVentures, startups are often financed by Life Sciences Partners, VI Partners AG, Prolog Ventures. The meaningful sponsors for the fund in investment in the same round are VI Partners AG, Seventure Partners, PMV. In the next rounds fund is usually obtained by Life Sciences Partners, Neomed Management, Ysios Capital.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Ai Hexin Touzi | China, Liaoning, Shenyang |
| Beijing Huadian Shidai Technology Development | Beijing, Beijing, China |
| Beijing Zhiyun Asset Management | Beijing, Beijing Shi, China |
| Blue Pool Capital | China, Hong Kong, Hong Kong Island |
| China Reinsurance Group | Beijing, Beijing, China |
| Hangzhou Yongyuan | China, Hangzhou, Zhejiang |
| RoseRock | Bryan, Texas, United States |
| The MasterCard Foundation | Canada, Ontario, Toronto |
| Tibet Jiuzheng Capital Investment | China, Shanxi, Xizhang |
| Tibet Kexin Venture Investment Partnership (L.P.) | Chengguan District, China, Lhasa |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Evommune | $83M | 09 Sep 2021 | California, United States | ||
Muna Therapeutics | $73M | 09 Jul 2021 | Copenhagen, Hovedstaden, Denmark | ||
Innovative Molecules | $23M | 09 Jun 2021 | Munich, Bayern, Germany | ||
| $188M | 14 Jan 2021 | The Netherlands, North Holland, Netherlands | |||
Imcyse | $33M | 18 Jun 2019 | Liège, Liège, Belgium | ||
Lumeon | $28M | 04 Dec 2018 | London, England, United Kingdom | ||
Aelin Therapeutics | $31M | 11 Dec 2017 | Wisconsin, United States | ||
Nouscom | $49M | 06 Nov 2017 | Basel, Basel-City, Switzerland | ||
Eloxx | $8M | 02 Aug 2017 | Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Evommune | $83M | 09 Sep 2021 | California, United States | ||
Muna Therapeutics | $73M | 09 Jul 2021 | Copenhagen, Hovedstaden, Denmark | ||
Innovative Molecules | $23M | 09 Jun 2021 | Munich, Bayern, Germany | ||
| $188M | 14 Jan 2021 | The Netherlands, North Holland, Netherlands | |||
Imcyse | $33M | 18 Jun 2019 | Liège, Liège, Belgium | ||
Lumeon | $28M | 04 Dec 2018 | London, England, United Kingdom | ||
Aelin Therapeutics | $31M | 11 Dec 2017 | Wisconsin, United States | ||
Nouscom | $49M | 06 Nov 2017 | Basel, Basel-City, Switzerland | ||
Eloxx | $8M | 02 Aug 2017 | Massachusetts, United States |
